TransDigm Group said on Monday it will acquire Simmonds Precision Products from RTX Corp for about $765 million in cash.

image for news TransDigm to acquire Simmonds Precision Products for about $765 million

Wheaton Precious Metals: High Margins, Zero Debt — Positive

WPM   Seeking Alpha — June 30, 2025

Wheaton Precious Metals' streaming model delivers high-margin, low-risk exposure to precious metals, supported by a diversified, long-lived portfolio and fortress balance sheet. Record cash flows, zero debt, and robust organic growth pipeline position Wheaton for ~40% cash flow growth over five years, justifying premium valuation multiples. Key risks are commodity price volatility and project execution, but contractual protections and low-cost streams mitigate downside, supporting superior risk-adjusted returns.

image for news Wheaton Precious Metals: High Margins, Zero Debt

Rocket Lab ($RKLB) | Eve Air Mobility ($EVEX) | JinkoSolar ($JKS) | Hut 8 ($HUT) — Positive

HUT  JKS  RKLB   Green Stock News — June 30, 2025

Welcome to the Green Stock News brief for Monday June 30th. Here are today's top headlines: Rocket Lab (NASDAQ: RKLB) has successfully launched its 68th Electron rocket from New Zealand, deploying a satellite for a commercial customer in a mission called “Symphony In The Stars.

image for news Rocket Lab ($RKLB) | Eve Air Mobility ($EVEX) | JinkoSolar ($JKS) | Hut 8 ($HUT)

CHICAGO , June 30, 2025 /PRNewswire/ -- Today Conagra Brands, Inc. (NYSE: CAG) announced that it has completed the divestiture of the Van de Kamp's® and Mrs. Paul's® brands to High Liner Foods.

image for news Conagra Brands Completes Divestiture of Van de Kamp's® and Mrs. Paul's® Brands to High Liner Foods

Boxlight Celebrates Ruby Jubilee at ISTELive 25 and ASCD Annual 25 — Neutral

BOXL   Business Wire — June 30, 2025

DULUTH, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL)—recognized as one of the top ed-tech companies in the world for innovative solutions that enhance communication and collaboration in educational institutions and businesses—will mark its 40th anniversary at ISTELive 25 and ASCD Annual 25, June 29–July 2 in San Antonio, Texas. Attendees who visit Booth #2918 will experience the company's latest innovations and see firsthand how Boxlight continues to evolve, inspire and deliver on.

image for news Boxlight Celebrates Ruby Jubilee at ISTELive 25 and ASCD Annual 25

Amgen's gastric cancer drug meets late-stage trial goal — Positive

AMGN   Reuters — June 30, 2025

Amgen said on Monday its experimental cancer therapy, when combined with chemotherapy, met the main goal in a late-stage trial.

image for news Amgen's gastric cancer drug meets late-stage trial goal

KANZHUN LIMITED Announces Pricing of Share Offer — Neutral

BZ   GlobeNewsWire — June 30, 2025

BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the pricing of its share offer (the “Share Offer”) of an aggregate of 34,500,000 Class A ordinary shares of the Company, including 4,500,000 Class A ordinary shares offered pursuant to the Company's full exercise of the offer size adjustment option. The Share Offer is comprised of a Hong Kong public offering (the “Hong Kong Public Offering”), and an international offering (the “International Offering”).

image for news KANZHUN LIMITED Announces Pricing of Share Offer

US indices firm as S&P 500 and Nasdaq rise on tech gains. Meta and Palantir lead, trade hopes support the stock market while traders await Fed clarity.

image for news S&P500 Today: Meta, Palantir Drive Tech Stocks as US Indices Firm on Trade

Medicus to acquire UK biotech Antev in share deal worth up to $65m — Positive

MDCX   Proactive Investors — June 30, 2025

Medicus Pharma (NASDAQ:MDCX) has agreed to acquire Antev, a UK-based drug developer working on treatments for prostate conditions, in a share-based deal that could be worth up to US$65 million in future milestone payments. Under the terms of the agreement, Antev shareholders will receive 2.67 million Medicus shares, equivalent to around 17% of the enlarged company, and worth $7.7 million at current prices.

image for news Medicus to acquire UK biotech Antev in share deal worth up to $65m

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Impact BioMedical Inc. (NYSE American: IBO) and Dr Ashleys Limited is fair to Impact shareholders. Halper Sadeh encourages Impact shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Impact and its board violated.

image for news IBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Impact BioMedical Inc. Is Fair to Shareholders

Shell Boosts Natural Gas Output at Norway's Ormen Lange Field — Positive

SHEL   Zacks Investment Research — June 30, 2025

Shell boosts Europe's gas security as Ormen Lange's subsea tech raises recovery rate to 85%, adding up to 50 BCM of supply.

image for news Shell Boosts Natural Gas Output at Norway's Ormen Lange Field

Petrobras Taps Fugro for Critical Subsea Inspection Contracts — Positive

PBR   Zacks Investment Research — June 30, 2025

PBR deepens its strategic partnership with Fugro through four key offshore contracts focused on innovation, safety and long-term energy resilience.

image for news Petrobras Taps Fugro for Critical Subsea Inspection Contracts

Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell? — Negative

CLB   Zacks Investment Research — June 30, 2025

CLB struggles with declining revenues, geopolitical risks, margin compression and weak U.S. demand, creating uncertainty around growth and profitability prospects.

image for news Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?

Pagaya Technologies Ltd. (PGY) Moves 9.6% Higher: Will This Strength Last? — Positive

PGY   Zacks Investment Research — June 30, 2025

Pagaya Technologies Ltd. (PGY) witnessed a jump in share price last session on above-average trading volume.

image for news Pagaya Technologies Ltd. (PGY) Moves 9.6% Higher: Will This Strength Last?

Calix to Post Second Quarter 2025 Results on July 21, 2025 — Neutral

CALX   Business Wire — June 30, 2025

SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE:CALX) today announced that on Monday, July 21, 2025, after market close, the company will post on the Calix Investor Relations website its second quarter 2025 stockholder letter for the period ended June 28, 2025. The posting of the stockholder letter will be announced over the newswire with a link to the letter to stockholders available at https://investor-relations.calix.com/. Calix will host a conference call to discuss these results the f.

image for news Calix to Post Second Quarter 2025 Results on July 21, 2025

Concentrix Releases 2025 Sustainability Report – ‘The Power of One' — Neutral

CNXC   GlobeNewsWire — June 30, 2025

NEWARK, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC ), a global technology and services leader, today released its 2025 Sustainability Report – The Power of One , spotlighting the company's bold strides toward its 2030 ESG goals across climate action, culture, innovation, community impact, and ethical business.

image for news Concentrix Releases 2025 Sustainability Report – ‘The Power of One'

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $SITM #MEMS--SiTime Corporation (NASDAQ: SITM), the Precision Timing company, today announced its TimeFabric™ software suite. TimeFabric, combined with SiTime's oscillators and clocks, delivers up to 9X more accurate time synchronization than quartz-based solutions, enabling higher system performance and utilization in AI data centers. The TimeFabric software suite consists of two modules: IEEE 1588 standards-compliant synchronization software, as well as proprietary te.

image for news SiTime Enhances AI Data Center Performance and Utilization with TimeFabric Software Suite

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall survival (OS) at a pre-specified interim analysis. Bemarituzumab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in OS as compared to placebo plus chemotherapy in people living with unresectable locally.

image for news Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

3 Growth Stocks to Take Profits On — Negative

PLTR   The Motley Fool — June 30, 2025

When investing in stocks, it is important to understand how valuation works. You would not buy a house for $1 million if the recent comps for a similar home were $500,000, would you?

image for news 3 Growth Stocks to Take Profits On

Alphabet's Google said on Monday it has struck a deal to buy power from a project in Virginia fueled by fusion, the reaction that powers the sun and the stars but is not yet commercial on Earth.

image for news Google strikes deal to buy fusion power from MIT spinoff Commonwealth